PTGS2 and neoplasm: COX is the rate-limiting enzyme of prostaglandin synthesis, and under pathological conditions, COX-2 promotes tumor cell proliferation, inhibits cell apoptosis, promotes the release of angiopoietin, inhibits endothelial apoptosis, and activates MMPs (matrix metalloproteinases), thus inducing tumor angiogenesis.